LENZ Therapeutics, Inc. (LENZ) is currently trading at $4.6 with a Wall Street consensus price target of $32.0, implying potential upside of 595.7% over the next 12 months. 7 analysts currently cover LENZ, with a consensus rating of Buy - 86% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $60.0, while the most cautious has a target of $12.0.
LENZ operates in the Healthcare sector with a market capitalisation of $145M. The stock is down 71.3% year-to-date and is currently trading near the lower end of its 52-week range of $4.54 – $50.4.
Other Healthcare stocks with comparable size and valuation.
Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.
Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.
StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.
View Full Rankings →